Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Li Xu, Juan Feng, Guangxun Gao & Hailong Tang. (2019) Momelotinib for the treatment of myelofibrosis. Expert Opinion on Pharmacotherapy 20:16, pages 1943-1951.
Read now
Read now
Paolo Strati, William F. Glass, Maen Abdelrahim, Umut Selamet, Amanda Tchakarov, Biruh T. Workeneh, Srdan Verstovsek & Ala Abudayyeh. (2019) Renal complications of primary myelofibrosis. Leukemia & Lymphoma 60:2, pages 507-510.
Read now
Read now
Seiichi Okabe, Keisuke Miyazawa, Tomotaka Iguchi, Masahiko Sumi, Tomoiku Takaku, Yoshikazu Ito, Yukihiko Kimura, Hiromi Serizawa, Kiyoshi Mukai & Kazuma Ohyashiki. (2005) Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-β1. Leukemia & Lymphoma 46:4, pages 599-602.
Read now
Read now
J. Thiele & H. M. Kvasnicka. (2001) Comparative Effects of Interferon and Hydroxyurea on Bone Marrow Fibrosis in Chronic Myelogenous Leukemia. Leukemia & Lymphoma 42:5, pages 855-862.
Read now
Read now
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt-Graeff, Thomas Karl Zirbes, Florian Birnbaum, Christian Kressmann, Manuel Melguizo-Grahmann, Holger Frackenpohl, Claudia Sprungmann, Lutz-Dietrich Leder, Volker Diehl, Rudolf Zankovich, Hans Eckart Schaefer, Norbert Niederle & Robert Fischer. (2000) Bone Marrow Features and Clinical Findings in Chronic Myeloid Leukemia - A Comparative, Multicenter, Immunohistological and Morphometric Study on 614 Patients. Leukemia & Lymphoma 36:3-4, pages 295-308.
Read now
Read now
Niklas Zojer, Johannes Gobertus Meran, Michael Vesely, Helga Grüner, Jutta Ackermann, Christian Dellinger, Ilse Zimmer-Roth, Renate Heinz, Johannes Drach & Heinz Ludwig. (1999) Trisomy 13 is Associated with Poor Prognosis in Idiopathic Myelofibrosis with Myeloid Metaplasia. Leukemia & Lymphoma 35:3-4, pages 415-421.
Read now
Read now
Juergen Thiele, Hans Michael Kvasnicka, Robert Fischer & Volker Diehl. (1997) Clinicopathological Impact of the Interaction Between Megakaryocytes and Myeloid Stroma in Chronic Myeloproliferative Disorders: A Concise Update. Leukemia & Lymphoma 24:5-6, pages 463-481.
Read now
Read now
Articles from other publishers (52)
Hristo Popov, Tatiana Koleva, George S Stoyanov & Peter Ghenev. (2022) Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases. Cureus.
Crossref
Crossref
Maria Zingariello, Paola Verachi, Francesca Gobbo, Fabrizio Martelli, Mario Falchi, Maria Mazzarini, Mauro Valeri, Giuseppe Sarli, Christian Marinaccio, Johanna Melo-Cardenas, John D. Crispino & Anna Rita Migliaccio. (2022) Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice. Biomolecules 12:2, pages 234.
Crossref
Crossref
Maike Büttner‐Herold, Carsten Sticht, Thorsten Wiech & Stefan Porubsky. (2020) Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms. Histopathology 78:5, pages 738-748.
Crossref
Crossref
Paolo Strati, Maen Abdelrahim, Umut Selamet, Valda D. Page, Sherry A. Pierce, Srdan Verstovsek & Ala Abudayyeh. (2019) Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis. Annals of Hematology 98:7, pages 1611-1616.
Crossref
Crossref
Seung-Woo Baek, Ji Young Moon, Hyewon Ryu, Yoon-Seok Choi, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Samyoung Kim & Deog-Yeon Jo. (2018) Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study. The Korean Journal of Internal Medicine 33:4, pages 790-797.
Crossref
Crossref
Anthony D. Whetton, Norhaida Che Azmi, Stella Pearson, Ewa Jaworska, Liqun Zhang, Rognvald Blance, Alexandra C. Kendall, Anna Nicolaou, Samuel Taylor, Andrew J.K. Williamson & Andrew Pierce. (2016)
MPL W515L expression induces TGFβ secretion and leads to an increase in chemokinesis
via
phosphorylation of THOC5
. Oncotarget 7:10, pages 10739-10755.
Crossref
Crossref
Arun Rajasekaran, Thuy-Trang Ngo, Maen Abdelrahim, William Glass, Amber Podoll, Srdan Verstovsek & Ala Abudayyeh. (2015) Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib. BMC Nephrology 16:1.
Crossref
Crossref
Glauco Akelinghton Freire Vitiello, Roberta Losi Guembarovski, Carlos Eduardo Coral de Oliveira, Marla Karine Amarante, Aparecida de Lourdes Perim & Maria Angelica Ehara Watanabe. (2015) Involvement of transforming growth factor beta-1 (TGFβ1) cytokine and FOXP3 transcription factor genetic polymorphisms in hematological malignancies. Brazilian Archives of Biology and Technology 58:4, pages 553-561.
Crossref
Crossref
Christophe Desterke, Christophe Martinaud, Nadira Ruzehaji & Marie-Caroline Le Bousse-Kerdilès. (2015) Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis. Mediators of Inflammation 2015, pages 1-16.
Crossref
Crossref
Paulo Vidal Campregher. (2014) Does angiogenesis matter in primary myelofibrosis?. Revista Brasileira de Hematologia e Hemoterapia 36:5, pages 311-312.
Crossref
Crossref
Judit Bedekovics, Attila Kiss, Lívia Beke, Katalin Károlyi & Gábor Méhes. (2013) Platelet derived growth factor receptor-beta (PDGFRβ) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis. Virchows Archiv 463:1, pages 57-65.
Crossref
Crossref
R. Paule, M. Ponsoye, V. Gueutin, G. Deray & H. Izzedine. (2013) Glomérulopathies associées aux syndromes myéloprolifératifs. La Revue de Médecine Interne 34:6, pages 369-372.
Crossref
Crossref
Samar M. Said, Nelson Leung, Sanjeev Sethi, Lynn D. Cornell, Mary E. Fidler, Joseph P. Grande, Sandra Herrmann, Ayalew Tefferi, Vivette D. D'Agati & Samih H. Nasr. (2011) Myeloproliferative neoplasms cause glomerulopathy. Kidney International 80:7, pages 753-759.
Crossref
Crossref
Effrosyni Apostolidou, Hagop Kantarjian, Deborah Thomas, Ian Burger, Gautam Borthakur & Srdan Verstovsek. (2010) Phase II Study of Sunitinib in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis. Clinical Lymphoma Myeloma and Leukemia 10:4, pages 281-284.
Crossref
Crossref
Sara Galimberti, Martina Canestaro, Eugenio Ciancia, Rita Fazzi, Roberto Marasca & Mario Petrini. (2008) Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: An ex vivo study. Leukemia Research 32:8, pages 1324-1325.
Crossref
Crossref
Kumiko Matsui, Mayumi Adachi, Takayuki Tominaga, Kenji Shinohara & Toshiaki Kamei. (2008) Angioimmunoblastic T Cell Lymphoma Associated with Reversible Myelofibrosis. Internal Medicine 47:21, pages 1921-1924.
Crossref
Crossref
S. Galimberti, M. Canestraro, S. Pacini, R. Fazzi, E. Orciuolo, L. Trombi, L. Mattii, B. Battolla, A. Capodanno, P. Collecchi, F. Veroni, P. Simi, S. Piaggi, A. Casini & M. Petrini. (2008) PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells. Leukemia Research 32:1, pages 103-112.
Crossref
Crossref
Akira Shimada, Yasuhide Hayashi, Mizuho Ogasawara, Myoung-ja Park, Masahiko Katoh, Hisanori Minakami, Toshiyuki Kitoh, Seiji Kojima, Keisei Kawa & Hirokazu Kimura. (2007) Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders. Leukemia Research 31:9, pages 1199-1203.
Crossref
Crossref
Thomas Gastinne, Frédéric Vigant, Cecile Lavenu-Bombled, Orianne Wagner-Ballon, Micheline Tulliez, Hédia Chagraoui, Jean-Luc Villeval, Catherine Lacout, Michel Perricaudet, William Vainchenker, Karim Benihoud & Stéphane Giraudier. (2007) Adenoviral-mediated TGF-β1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development. Experimental Hematology 35:1, pages 64-74.
Crossref
Crossref
Hedia Chagraoui, Françoise Wendling & William Vainchenker. (2006) Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models. Best Practice & Research Clinical Haematology 19:3, pages 399-412.
Crossref
Crossref
Richard T. Silver. (2006) Long‐term effects of the treatment of polycythemia vera with recombinant interferon‐α. Cancer 107:3, pages 451-458.
Crossref
Crossref
Giovanni Barosi & Ronald Hoffman. (2005) Idiopathic Myelofibrosis. Seminars in Hematology 42:4, pages 248-258.
Crossref
Crossref
T Akiyama, T Matsunaga, T Terui, K Miyanishi, I Tanaka, T Sato, H Kuroda, R Takimoto, T Takayama, J Kato, N Yamauchi, K Kogawa, S Sakamaki, Y Hirayama, K Kohda & Y Niitsu. (2005) Involvement of transforming growth factor-β and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis. Leukemia 19:9, pages 1558-1566.
Crossref
Crossref
Verena Pihusch, Markus Pihusch, Marius Penovici, Hans J. Kolb, Erhard Hiller & Rudolf Pihusch. (2005) Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thrombosis Research 116:3, pages 233-240.
Crossref
Crossref
Melissa A Kacena, Ramesh A Shivdasani, Kimberly Wilson, Yougen Xi, Nancy Troiano, Ara Nazarian, Caren M Gundberg, Mary L Bouxsein, Joseph A Lorenzo & Mark C Horowitz. (2003) Megakaryocyte-Osteoblast Interaction Revealed in Mice Deficient in Transcription Factors GATA-1 and NF-E2. Journal of Bone and Mineral Research 19:4, pages 652-660.
Crossref
Crossref
Medhat Shehata, Josef D. Schwarzmeier, Martin Hilgarth, Rainer Hubmann, Markus Duechler & Heinz Gisslinger. (2004) TGF-β1 induces bone marrow reticulin fibrosis in hairy cell leukemia. Journal of Clinical Investigation 113:5, pages 676-685.
Crossref
Crossref
Pedro Gascon & Pranela Rameshwar. 2004. Molecular Basis of Chronic Myeloproliferative Disorders. Molecular Basis of Chronic Myeloproliferative Disorders
147
155
.
Marie-Caroline Le Bousse-Kerdilès & Marie-Claire Martyré. 2004. Molecular Basis of Chronic Myeloproliferative Disorders. Molecular Basis of Chronic Myeloproliferative Disorders
139
146
.
V Steunou, M C Le Bousse-Kerdilès, A Colin-Micouin, D Clay, S Chevillard & M C Martyré. (2003) Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia. Leukemia 17:10, pages 1998-2006.
Crossref
Crossref
Hédia ChagraouiMicheline TulliezTarek SmayraEmiko KomuraStéphane GiraudierTheodore YunNathalie LassauWilliam VainchenkerFrançoise Wendling. (2003) Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood 101:8, pages 2983-2989.
Crossref
Crossref
Hédia ChagraouiEmiko KomuraMicheline TulliezStéphane GiraudierWilliam VainchenkerFrançoise Wendling. (2002) Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice. Blood 100:10, pages 3495-3503.
Crossref
Crossref
Helena R.C. Segreto, Alice T. Ferreira, Edna T. Kimura, Marcello Franco, Mizue I. Egami, Maria Regina R. Silva & Roberto A. Segreto. (2002) Amifostine does not prevent activation of TGFβ1 but induces smad 7 activation in megakaryocytes irradiated in vivo. American Journal of Hematology 71:3, pages 143-151.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Dietrich Wilhelm Beelen, Guelken Cicek, Lutz-Dietrich Leder & Ulrich Wilhelm Schaefer. (2002)
Dynamics of CD34
+
Progenitor Cells Following Allogeneic Bone Marrow Transplantation in Ph
1+
CML—An Immunohistochemical Study on 113 Patients with Sequential Trephine Biopsies
. Journal of Hematotherapy & Stem Cell Research 11:3, pages 565-574.
Crossref
Crossref
Pranela RameshwarDeval D. JoshiPrem YadavJing QianPedro GasconVictor T. ChangDevashish AnjariaJonathan S. HarrisonXiaosong Song. (2001) Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis. Blood 97:10, pages 3025-3031.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Dietrich Wilhelm Beelen, Uta Flucke, Christian Spoer, Svetlana Paperno, Lutz-Dietrich Leder & Ulrich Wilhelm Schaefer. (2001) Megakaryopoiesis and Myelofibrosis in Chronic Myeloid Leukemia after Allogeneic Bone Marrow Transplantation: An Immunohistochemical Study of 127 Patients. Modern Pathology 14:2, pages 129-138.
Crossref
Crossref
Claudia Wickenhauser, Beate Schmitz, Stephan Ernst Baldus, Franc Henze, Parvis Farahmand, Semra Frimpong, Jürgen Thiele & Robert Fischer. (2000) Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte–fibroblast interactions in human bone marrow. Leukemia Research 24:12, pages 1013-1021.
Crossref
Crossref
J Thiele, H M Kvasnicka, A Schmitt‐Graeff, L D Leder & H E Schaefer. (2001)
Changing patterns of histological subgroups during therapy of Ph
1+
chronic myelogenous leukaemia
. Histopathology 37:4, pages 355-362.
Crossref
Crossref
Pranela Rameshwar, Ramaswamy Narayanan, Jing Qian, Thomas N. Denny, Cristina Colon & Pedro Gascon. (2000) NF-κB as a Central Mediator in the Induction of TGF-β in Monocytes from Patients with Idiopathic Myelofibrosis: An Inflammatory Response Beyond the Realm of Homeostasis. The Journal of Immunology 165:4, pages 2271-2277.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt-Graeff, Gabriela Cvetanovska, Nicole Blum & Hans Eckart Schaefer. (2000) Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential Trephine Biopsies of the Bone Marrow. Modern Pathology 13:8, pages 888-896.
Crossref
Crossref
Juergen Thiele, Hans M. Kvasnicka, Annette Schmitt-Graeff, Susanne Bundschuh, Teresa Biermann, Gernod Roessler, Maria Wasmus, Volker Diehl, Rudolf Zankovich & Hans E. Schaefer. (2000) Effects of Chemotherapy (Busulfan-Hydroxyurea) and Interferon-Alfa on Bone Marrow Morphologic Features in Chronic Myelogenous Leukemia. American Journal of Clinical Pathology 114:1, pages 57-65.
Crossref
Crossref
M. C. Le Bousse-Kerdilès & M. C. Martyré. (2000) Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. Springer Seminars in Immunopathology 21:4, pages 491-508.
Crossref
Crossref
Ayalew TefferiRuben A. MesaDavid M. NagorneyGeorgene SchroederMurray N. Silverstein. (2000) Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 95:7, pages 2226-2233.
Crossref
Crossref
Ayalew TefferiRuben A. MesaDavid M. NagorneyGeorgene SchroederMurray N. Silverstein. (2000) Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 95:7, pages 2226-2233.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt‐Graeff, Marlene Spohr, Volker Diehl, Rudolf Zankovich, Norbert Niederle & Lutz‐Dietrich Leder. (2001) Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study. British Journal of Haematology 108:1, pages 64-71.
Crossref
Crossref
Wing Y. Au, Kwok W. Chan, Sing L. Lui, Clarence C.K. Lam & Yok L. Kwong. (1999) Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. American Journal of Kidney Diseases 34:5, pages 889-893.
Crossref
Crossref
Juergen Thiele, Hans Michael Kvasnicka & Barbara Boeltken. (1999) Resident bone marrow macrophages in idiopathic (primary) myelofibrosis (IMF): a histochemical and morphometric study on sequential trephine biopsies. Leukemia Research 23:11, pages 983-985.
Crossref
Crossref
Soo‐Young Yoon, Chin‐Yang Li, Ruben A. Mesa & Ayalew Tefferi. (2002) Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology 106:3, pages 682-688.
Crossref
Crossref
Beate Schmitz, Claudia Wickenhauser, Juergen Thiele, Semra Frimpong, Carina Brockbals, Barbara Selbach, Cornelia Mueller & Robert Fischer. (1999) Megakaryocyte induced fibroblast proliferation is enhanced by costimulation with IL-6/IL-3 and dependent on secretory and adhesion events. Leukemia Research 23:8, pages 723-729.
Crossref
Crossref
Pranela Rameshwar, Victor T. Chang, Usha F. Thacker & Pedro Gascón. (1998) Systemic transforming growth factor-beta in patients with bone marrow fibrosis—pathophysiological implications. American Journal of Hematology 59:2, pages 133-142.
Crossref
Crossref
Beate Schmitz, Juergen Thiele, Frauke Otto, Parvis Farahmand, Franc Henze, Semra Frimpong, Claudia Wickenhauser & Robert Fischer. (1998) Evidence for integrin receptor involvement in megakaryocyte-fibroblast interaction: A possible pathomechanism for the evolution of myelofibrosis. Journal of Cellular Physiology 176:3, pages 445-455.
Crossref
Crossref
JUERGEN THIELE, CLAUDIA WICKENHAUSER, CHRISTOPH NEUWIRTH, HANS-JOERG SCHULZE, UTA FLUCKE, HANS MICHAEL KVASNICKA, PETER BORCHMANN, RAINER KRECH & ROBERT FISCHER. (1998) Effect of IFN-α on Normal Human Hematopoiesis: An Immunohistochemical and Morphometric Study on Trephine Biopsy Specimens. Journal of Interferon & Cytokine Research 18:4, pages 247-253.
Crossref
Crossref
Sharon O'Kane & Mark W.J. Ferguson. (1997) Transforming growth factor βs and wound healing. The International Journal of Biochemistry & Cell Biology 29:1, pages 63-78.
Crossref
Crossref